TrialEuropean heart journal2019

Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial.

Stefan H Hohnloser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.